Behavioral health

The research, published in JAMA Network Open, found no difference in visit frequency, initiation of medication use or adverse outcomes between patients who were treated by clinicians with either high or low levels of telehealth use.

Its frequent usage was also found to improve sensory processing.  

The prescription digital therapeutics company will also put non-ADHD products in development on hold to "conserve capital and focus."

Veradigm is also keen on bringing its behavioural health data to Holmusk's rapidly growing database.  

The company eyes overseas expansion and wants to offer more telemental health services.

According to an analysis published in JAMA Network Open, many mental health apps provided similar offerings, but frequently lacked accessibility features.

Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.

However, these tools are not yet able to provide personalised advice.

The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."

Click Therapeutics received FDA Breakthrough Device Designation for a prescription digital therapeutic for episodic migraine, and Superior HealthPlan announced a home care partnership with MedArrive and Brave Health.